Propranolol for severe infantile hemangiomas: follow-up report. - Wikidata - wikimedia - TriplyDB

Propranolol for severe infantile hemangiomas: follow-up report.

Propranolol for severe infantile hemangiomas: follow-up report.

http://www.wikidata.org/entity/Q43286268

about

Cutaneous lesions of the nose Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants Cardiovascular drugs in the treatment of infantile hemangioma Propranolol in use for treatment of complex infant hemangiomas: literature review regarding current guidelines for preassessment and standards of care before initiation of therapy Repurposing of approved cardiovascular drugs Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease Kasabach-Merritt phenomenon in Chinese children: Report of 19 cases and brief review of literature Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.Successful treatment of mild pediatric kasabach-merritt phenomenon with propranolol monotherapy Management of periorbital hemangioma by intralesional glucocorticoids and systemic propranolol: a single-center retrospective study Developing a Nanoparticle-Delivered High-Efficacy Treatment for Infantile Hemangiomas Using a Mouse Hemangioendothelioma Model.Beta-blockers as therapy for infantile hemangiomas Effects of propranolol and isoproterenol on infantile hemangioma endothelial cells in vitro Infantile haemangioma: part II. Risks, complications and treatment.Hemangiomas revisited: the useful, the unusual and the new. Part 2: endangering hemangiomas and treatment.Periocular capillary hemangiomas: indications and options for treatment.Initiation and use of propranolol for infantile hemangioma: report of a consensus conference.Management of infantile hemangiomas: current trends Topical propranolol therapy for infantile hemangiomas.The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies.Propranolol therapy for infantile hemangioma is less toxic but longer in duration than corticosteroid therapy.Biology of infantile hemangioma Infantile hemangioma in a v2 distribution: treatment with nadolol Haemangioma of infancy: two case reports with an overdose of propranolol.The use of propranolol in the management of periocular capillary haemangioma--a systematic review Pulsed dye laser therapy for infantile hemangiomas: a systemic review and meta-analysis.Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol.Oral propranolol for the treatment of periorbital infantile hemangioma: a preliminary report from oman.Effectiveness and Safety of Oral Propranolol versus Other Treatments for Infantile Hemangiomas: A Meta-Analysis.Treatment with propranolol for infantile hemangiomas: A case series of 106 infants.Evaluation of intra-lesional corticosteroids in the treatment of peri-ocular haemangioma of infancy: still an alternative besides propranolol.Clinical efficacy of propranolol in the treatment of hemangioma and changes in serum VEGF, bFGF and MMP-9 Hemangioma treatment with pulsed dye laser-distinct parameters used between neonatal and non-neonatal patients.Propranolol: Effectiveness and Failure in Infantile Cutaneous Hemangiomas Propranolol treatment for infantile hemangioma does not increase risk of childhood wheezing.Propranolol is an effective treatment for airway haemangiomas: a critical analysis and meta-analysis of published interventional studies Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation A prospective study to assess the efficacy and safety of oral propranolol as first-line treatment for infantile superficial hemangioma.β-blockers: a novel class of antitumor agents.

P2860

Q21203651-90F6BD27-EDF1-40B1-AF09-FC3A3751898D Q24187442-CF8F6BC2-AA90-4A18-8702-4FFA020C26AA Q26769978-5D0C5780-AA38-4309-9658-396733279696 Q27005682-3794D4CA-881E-4ECE-9870-4DA04738A90D Q28074453-8ACB5E1B-346C-416C-8332-26AD8EA19C4B Q30992212-AFD92BA8-5A20-402D-9CE7-BA22B75BC987 Q32174211-11CEFE8E-7098-424E-BB37-0CB0EE5A2C02 Q33425445-F59B329F-B6A1-434A-B61D-07EF4D0FACBD Q33577048-FDEC298C-0080-413C-9780-CED5E74C8ED1 Q33745400-190EE524-F2CC-4299-B72C-B97D88C4E574 Q33756270-ED77937A-FF57-43B3-A371-8CB0708D68F4 Q33802563-A7961F36-33A9-496A-A63F-7B5CC37103DF Q33832594-32BEEA96-5684-4785-86B4-32B3C9AABEFF Q33837509-9C4434E5-1279-4781-AA5B-84534B547898 Q33898263-DF2E3CB1-996B-417E-9AAB-63EEDA0A6F50 Q33909972-C25D6378-49A2-44C4-840B-84CAF89E8CD7 Q33941063-86C816CC-3B50-4307-9AD1-503D819C7274 Q34034894-FC70647A-C937-4769-988E-100AA952C06C Q34052390-2542EB5F-8991-4E6D-A30B-7E02490F217B Q34091598-0DE4FCA4-9F1F-4A60-863D-DE88D77630B1 Q34209504-D716F10E-9C65-434B-899A-B3D7DB70CAA5 Q34742712-6C2ED747-CFFD-487C-BF36-CA16625D0865 Q34867993-DA0EEF8E-319C-4C76-A582-3FD9EC147B22 Q35198657-A0AB77D6-FE04-4780-9BA3-B4D3A520FE8E Q35219212-C66ECBA4-0AE7-4569-9188-7C97140DF592 Q35358798-F20FD953-39BC-48DB-B8A0-45A1149E284A Q35400742-30C3259B-B252-4B3D-963B-664176C2427B Q35603555-27080942-3BEB-4C96-9F70-2AB794D8F2A4 Q35646495-86B59DFE-087D-42A4-81AD-D0D3D7A65D27 Q35777099-DEE6ADE7-04AC-4DBD-B0CC-6574DE994F40 Q35803457-A1379016-042A-440A-94B4-04C88B630D16 Q35851345-80402E1E-9104-4F6D-B131-9A90F474B69C Q35942857-56566DF3-1B44-48A5-A263-106ED2575ABA Q36058730-35B8F4C8-BA0A-4E57-9A3E-765853ED59C0 Q36164771-F6E724FB-98AF-46FE-9943-0637B681DC21 Q36299241-698B1C7E-D5A5-458A-9238-78D9F1C74CAC Q36310708-D8F949DD-C0E8-4C37-8054-69CD6F2FAD87 Q36440738-5D8C2648-7D2D-489E-9856-DFE92846FCC2 Q36442155-F7C07318-4688-47FC-A53F-A6ADBFC3E0F0 Q36443830-AFBBC655-EDF1-4DF3-8A48-7E50B78BAD06

P2860

Propranolol for severe infantile hemangiomas: follow-up report.

http://www.wikidata.org/entity/Q43286268

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Propranolol for severe infantile hemangiomas: follow-up report.

@en

Propranolol for severe infantile hemangiomas: follow-up report.

@nl

type

label

Propranolol for severe infantile hemangiomas: follow-up report.

@en

Propranolol for severe infantile hemangiomas: follow-up report.

@nl

prefLabel

Propranolol for severe infantile hemangiomas: follow-up report.

@en

Propranolol for severe infantile hemangiomas: follow-up report.

@nl

P1433

Q43286268-81662B81-541B-47C6-A871-A81AA7AB64DC

P1476

Q43286268-7A3A46B7-DFD7-4A0F-935D-371B405B47F8

P2093

Q43286268-09115077-A7C5-4F46-B801-522578A0BBEC

Q43286268-3464183E-CA9C-4186-AA29-3541EB3410FB

Q43286268-3783757B-7405-48E1-AF7E-D1B2CF7C9CA0

Q43286268-4A7C90D7-60B2-4D31-AD95-60A60150FB76

Q43286268-4BAB4800-866B-48F6-AFA7-8BDA06C6585C

Q43286268-6F08AD95-D16D-4AB8-A5C3-3666973C075A

Q43286268-7CDF4061-9F76-4AFD-BBD2-A33120AFB201

Q43286268-AA8389E2-F0F9-4349-8AF7-DBAE96707548

Q43286268-C77C0616-AF68-4B8F-B7AF-63B70A721B63

Q43286268-D523D13A-E1D9-4424-A182-CD9F25FA8196

P304

Q43286268-87C2A792-48D2-4705-95F5-B2359AE7B6FA

P31

Q43286268-F611814A-E2DE-4C7B-BD64-A2691D092FE6

P356

Q43286268-84BC765F-ABFF-479D-B5AF-CDC42DF4B1ED

P407

Q43286268-A442DA21-6B19-4281-9FE6-C011CF98BEA7

P433

Q43286268-CD3A3D50-EB49-487D-AEDE-FE5C28655570

P478

Q43286268-E1B2D21B-985B-4FF7-BD58-017F42D48F36

P50

Q43286268-B9A05AF6-21A4-42CB-BC1C-69702BCE818A

Q43286268-DDD8C12B-0532-4D0A-AF6D-33FC3FD857D3

P577

Q43286268-31E505D4-E3CA-4579-BCAC-48ABB263346D

P698

Q43286268-D3B1AA9C-17CF-4957-ACF1-8991A90EDC45

P356

P1433

P1476

Propranolol for severe infantile hemangiomas: follow-up report.

@en

P2093

Alain Taïeb

http://www.w3.org/2001/XMLSchema#string

Christine Léauté-Labrèze

http://www.w3.org/2001/XMLSchema#string

Dan Lipsker

http://www.w3.org/2001/XMLSchema#string

Elisabeth Dupuis

http://www.w3.org/2001/XMLSchema#string

Eric Dumas de la Roque

http://www.w3.org/2001/XMLSchema#string

Juliette Mazereeuw-Hautier

http://www.w3.org/2001/XMLSchema#string

Jérôme Berge

http://www.w3.org/2001/XMLSchema#string

Nicolas Grenier

http://www.w3.org/2001/XMLSchema#string

Pierre Vergnes

http://www.w3.org/2001/XMLSchema#string

Véronique Sans

http://www.w3.org/2001/XMLSchema#string

P304

e423-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1542/PEDS.2008-3458

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Khaled Ezzedine

Franck Boralevi

P577

2009-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19706583

http://www.w3.org/2001/XMLSchema#string